XML 24 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions, Dispositions and Other Transactions
3 Months Ended
Mar. 31, 2014
Acquisitions, Dispositions and Other Transactions  
Acquisitions, Dispositions and Other Transactions

(2) Acquisitions, Dispositions and Other Transactions

Uppercase Living

On March 14, 2014, UAI acquired substantially all the assets of Uppercase Living, LLC, a direct seller of an extensive line of customizable vinyl expressions for display on walls. We assumed $512,195 of sellers liabilities that existed prior to the transaction and agreed to issue 12,725 shares of our common stock, par value $0.0001 ("Common Stock") to the seller at a fair value of $96,706 on the acquisition date. We have also agreed to deliver 16,195 shares of our common stock at a fair value of $123,081 to an escrow account for up to 24 months that will be issued to the seller upon remediation of certain close conditions. Since we did not deliver the shares of our Common Stock until April 2014, we recorded a payable as of the acquisition date totaling $219,787. We also agreed to pay the seller three subsequent contingent payments equal to 10% of Earnings before Interest, Taxes, Depreciation and Amortization ("EBITDA") for each of the years ending 2014 to 2016. We have not recorded any contingent earn-out as of March 31, 2014. Goodwill arising from the transaction totaled $469,065. We recognized goodwill in the acquisition as the business had management in place, established distribution methods, an established consultant base and brand recognition. In addition to these factors, goodwill was recognized in this transaction because of the expected synergies that management anticipates and the overall benefits of bringing additional consultants into the CVSL network.

Opening balance sheet for Uppercase Living acquisition on March 14, 2014

The following summary represents the fair value of UAI as of the acquisition date and is subject to change following management's final evaluation of the fair value assumptions.

 
  UAI  

Assets

       

Current assets:

       

Cash and cash equivalents

  $ 2,000  

Accounts receivable

    1,742  

Inventory

    96,497  
       

Total current assets

    100,239  

Property, plant and equipment

    23,230  

Goodwill

    469,065  

Other assets

    16,366  
       

Total assets

  $ 608,900  
       
       

Liabilities and stockholders' equity

       

Current liabilities:

       

Accounts payable—trade

  $ 267,337  

Accrued commissions

    79,003  

Deferred revenue

    28,399  

Other current liabilities

    96,706  
       

Total current liabilities

    471,445  

Other long-term liabilities

    137,455  
       

Total liabilities

    608,900  

Stockholders' equity

     
       

Total stockholders' equity

     

Total liabilities and stockholders' equity

  $ 608,900  
       
       

Dispositions

During the quarter ended March 31, 2014, TLC sold an industrial building at ECO Business Park in Frazeysburg, Ohio for gross proceeds of $1,333,857. Gain on sale of the asset was $271,970 that is included in the consolidated statements of operations. The gain was offset by a $6,043 loss on the sale of other assets.

The Longaberger Company

On March 18, 2013, the Company acquired a controlling interest in TLC, a direct-selling business based in Newark, Ohio. The transaction resulted in the Company acquiring 64.6% of the voting stock and 51.7% of all the stock in TLC in return for a $6,500,000 convertible note and a $4,000,000 promissory note. The acquisition was accounted for under the purchase method of accounting and TLC is a consolidated subsidiary of the Company.

Opening balance sheets for The Longaberger Company acquisition on March 18, 2013

The following summary represents the fair value of TLC as of the acquisition date.

 
  TLC  

Assets

       

Current assets:

       

Cash and cash equivalents

  $ 84,062  

Accounts receivable

    259,602  

Inventory

    19,892,740  

Prepaid expenses and other

    1,074,420  
       

Total current assets

    21,310,824  

Property, plant and equipment

    28,469,390  

Other assets

    3,946,570  
       

Total assets

  $ 53,726,784  
       
       

Liabilities and stockholders' equity

       

Current liabilities:

       

Accounts payable—trade

  $ 6,383,107  

Accounts payable—related party

     

Line of credit payable

    9,319,612  

Deferred revenue

    4,132,386  

Current portion of long-term debt

    354,390  

Other current liabilities

    3,962,045  
       

Total current liabilities

    24,151,540  

Long-term debt

    9,265,766  
       

Total liabilities

    33,417,306  
       

Stockholders' equity:

       

Stockholders' equity attributable to CVSL stockholders'

    10,500,000  

Stockholders' equity attributable to noncontrolling interest

    9,809,478  
       

Total stockholders' equity

    20,309,478  
       

Total liabilities and stockholders' equity

  $ 53,726,784  
       
       

The acquisition did not result in recognition of any intangible assets or goodwill.

TLC Results from Operations

The following table presents the operating results of TLC included in the Company's consolidated statements of operations for the 13 day period beginning March 19, 2013 to March 31, 2013.

Gross sales

  $ 3,998,530  

Program costs and discounts

    (1,031,970 )
       

Net sales

    2,966,560  

Costs of sales

    1,370,120  
       

Gross profit

    1,596,440  

Commissions and incentives

    604,404  

Selling, general and administrative

    906,007  
       

Operating profit

    86,029  

Interest expense, net

    37,488  
       

Net income

    48,541  

Net earnings attributable to noncontrolling interest

    23,445  
       

Net earnings attributed to CVSL

  $ 25,096  
       
       

Possible Issuance of Additional Common Stock under Share Exchange Agreement

On August 24, 2012 we entered into a Share Exchange Agreement (the "Share Exchange Agreement") with HCG and Rochon Capital Partners, Ltd. ("Rochon Capital"). Under the Share Exchange Agreement, in exchange for all of the capital stock of HCG, we issued 21,904,302 shares of our restricted common stock to Rochon Capital (the "Initial Share Exchange"). The shares of our Common Stock received by Rochon Capital totaled approximately 90% of our issued and outstanding stock at the time of issuance. The Initial Share Exchange was completed on September 25, 2012 and resulted in a change in control and HCG becoming our wholly-owned subsidiary.

Under the Share Exchange Agreement, Rochon Capital also purchased and has the right to an additional 25,240,676 shares of Common Stock (the "Additional Shares"). The second closing of the transactions and the issuance of the Additional Shares contemplated by the Share Exchange Agreement (the "Second Tranche Closing") was to occur on the date that was the later of: (i) the 20th calendar day following the date on which we first mailed an Information Statement to our shareholders; (ii) the date the Financial Industry Regulatory Authority ("FINRA") approved the Amendment; or (iii) the first business day following the satisfaction or waiver of all other conditions and obligations of the parties to consummate the transactions contemplated by the Share Exchange Agreement, or on such other date and at such other time as the parties may mutually determine.

On April 12, 2013, we filed Articles of Amendment to its Articles of Incorporation with the Florida Secretary of State to effect: (i) an increase in the number of authorized shares of the Corporation's common stock from 490,000,000 to 5,000,000,000 shares (prior to the Company's 1-for-20 reverse stock split effected on October 16, 2014 as described in Note 14) (the "Increase") and (ii) a change in the name of the Corporation to CVSL Inc. (the "Name Change") on May 27, 2013. The Company's shareholders holding a majority of its outstanding shares of common stock approved the Increase and the Name Change and the Articles of Amendment (the "Amendment") effecting such transactions.

However, at the time of the filing of the Amendment, Rochon Capital and CVSL each determined that it was not in the best interests of CVSL to consummate the Second Tranche Closing and the issuance of the Additional Shares at that time. As a result, the Share Exchange Agreement was amended on April 10, 2013 to provide that, among other things, the Second Tranche Closing will occur on the date specified in a written notice provided by Rochon Capital, which date shall not be prior to the 20th calendar day following the date on which we first mailed our Information Statement to our shareholders and the date the FINRA approves the Amendment.

The amendment to the Share Exchange Agreement also (a) clarifies and redefines the number of shares that are to be issued at the Second Tranche Closing as 25,240,676 shares of our Common Stock, or any portion thereof provided for in the notice from Rochon Capital and (b) modifies the date tied to certain restrictions set forth in Section 7.08 of the Share Exchange Agreement, since the Second Tranche Closing Date cannot be determined at this time. We have the ability to issue the Additional Shares to Rochon Capital, as agreed to in the Share Exchange Agreement, as amended, upon our receipt of written notice from Rochon Capital.